- Original brands
- The price on the pack
Privacy: may we measure how you found us? Never your name, number or health details.
May we remember how you found us, so we know which adverts are worth running? Allowing advertising also shares the value of a confirmed booking or payment, and the ad click it came from, with Google. We never share your name, contact details, medicines or anything about your health.

MRP, inclusive of all taxes
Delivered across India. ₹49 delivery, free above ₹999.
Pack: Tablet · 5mg + 50mg · 10`S
Prescription required — upload during checkout. No prescription? Place the order and a doctor will call you free of charge before it ships.
Original brandsFrom authorised sources
The price on the packNo inflated MRPs
Licensed pharmacyRx checked before packing
7 days to report a problemWrong or damaged item
Contains: Dapagliflozin (5mg) + Sitagliptin (50mg)
Zensita -D 50/5 mg Tablet contains Dapagliflozin (5mg) + Sitagliptin (50mg). Prescription required.
Zensita -D 50/5 mg Tablet is a prescription medicine containing Dapagliflozin (5mg) + Sitagliptin (50mg). It is used for type 2 diabetes mellitus (as an add-on to diet. It belongs to the group of medicines called DPP-4 inhibitor + SGLT2 inhibitor.
Tablet for oral use. The dose and how long you take it depend on what you are being treated for and how you respond. Do not take more, or for longer, than your doctor has advised.
The side effects seen most often with Zensita -D 50/5 mg Tablet are genital fungal infection, urinary tract infection, increased urination and thirst. Most are mild and settle as the body gets used to the medicine. Tell your doctor if one persists or worries you.
Before you start, tell your doctor about any liver, kidney or heart problem, whether you are pregnant, planning a pregnancy or breastfeeding, and every other medicine you take, including supplements and ayurvedic preparations. Some of them can change how Zensita -D 50/5 mg Tablet works.
Type 2 diabetes mellitus (as an add-on to diet and exercise) to improve glycaemic control in adults when dual therapy is appropriate.
Most side effects of Zensita -D 50/5 mg are mild and settle as the body gets used to the medicine. The ones reported most often are:
Stop the medicine and get help at once for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.
Tablet for oral use. Take as prescribed by the doctor, usually once daily; may be taken with or without food, preferably at the same time each day. Maintain adequate hydration; follow diet/exercise advice and monitor blood glucose.
Sitagliptin is a DPP-4 inhibitor that increases incretin hormones, thereby increasing insulin release and decreasing glucagon levels in a glucose-dependent manner. Dapagliflozin is an SGLT2 inhibitor that lowers blood glucose by increasing urinary glucose excretion through the kidneys.
Not for type 1 diabetes or diabetic ketoacidosis. Risk of dehydration and low blood pressure (more in elderly/diuretics); maintain fluids. SGLT2 inhibitors may increase risk of genital mycotic infections, UTIs and rare Fournier’s gangrene—seek care for genital pain/swelling/fever. Rare risk of pancreatitis with sitagliptin—stop and consult if severe abdominal pain occurs. Monitor kidney function before and during therapy; use with caution/avoid in significant renal impairment as advised by physician. Use caution if history of recurrent UTIs, ketoacidosis, alcoholism, low-carb intake, or surgery/acute illness (ketoacidosis risk).
If you miss a dose of Zensita-D 50/5 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
An overdose of this medicine can cause dehydration and a fall in blood pressure. It may cause low blood sugar, particularly if you also take other diabetes medicines. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.
Insulin and sulfonylureas (increased hypoglycaemia risk),diuretics (increased dehydration/hypotension risk),rifampicin and other strong enzyme inducers (may reduce sitagliptin effect),digoxin (sitagliptin may increase levels),other glucose-lowering drugs (additive effect)
Store below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.
Istamet D 50/5 Tablet,Kombiglyze XR 5/500 Tablet,Qtern 5/5 Tablet (dapagliflozin+saxagliptin),Glyxambi 10/5 Tablet (empagliflozin+linagliptin),Jardiance Duo 25/5 Tablet (empagliflozin+linagliptin)
Compiled from the manufacturer's prescribing information and the sources below, and reviewed by a registered pharmacist. It does not replace your own doctor's advice.
Medical disclaimer: product information is for awareness only and does not replace medical advice. For Rx medicines, a valid prescription is required. Consult your doctor or pharmacist for personalised guidance.